-transparent.png){kind=logo}
The effect of administration of 25 micrograms 24,25-dihydroxyvitamin D3 (24,25(OH)2D) combined with dihydrotachysterol (DHT2) on clinical, radiological, biochemical and bone histological parameters was assessed in ten children on chronic hemodialysis. Eight children had been treated with DHT2 prior to administration of 24,25(OH)2D. Addition of 24,25(OH)2D to the treatment resulted in a decrease in serum calcium values. Therefore higher doses of DHT2 were required to maintain serum-calcium levels between 2.4-2.8 mmol/l. Administration of 24,25(OH)2D did not modify the quality of bone, but histomorphometric investigation did show a significant reduction of the surface percentage of bone trabecula, in the iliac crest, covered with osteoclasts (oc%). Following the administration of 24,25(OH)2D an increase in bone mineralization was shown by X-rays of the wrists and measured by dual photonabsorptiometry. Addition of 24,25(OH)2D to the DHT2 treatment resulted in an increase in serum concentration of 24,25(OH)2D and a decrease in DHT2 levels. The present study suggests that administered 24,25(OH)2D interferes with DHT2 metabolism and increases DHT2 tolerance. Increased bone mineralization may be related to 24,25(OH)2D, a higher dose of DHT2 or both.
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
May 2000,
Clinical nephrology,
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
March 1974,
Science (New York, N.Y.),
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
July 1981,
Endocrinology,
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
April 1942,
Science (New York, N.Y.),
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
June 1992,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
October 1989,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
February 1993,
Bioscience reports,
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
April 2006,
Journal of cellular biochemistry,
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
August 1994,
Biochemical and biophysical research communications,
R van Diemen-Steenvoorde, and
R A Donckerwolcke, and
R Bosch, and
W J Visser, and
J A Raymakers, and
S A Duursma
January 1982,
The Quarterly journal of medicine,
